191 related articles for article (PubMed ID: 25031750)
1. Decreased expression of miR-204 is associated with poor prognosis in patients with breast cancer.
Li W; Jin X; Zhang Q; Zhang G; Deng X; Ma L
Int J Clin Exp Pathol; 2014; 7(6):3287-92. PubMed ID: 25031750
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
Dong LL; Chen LM; Wang WM; Zhang LM
Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
[TBL] [Abstract][Full Text] [Related]
3. Clinical potential of miR-940 as a diagnostic and prognostic biomarker in breast cancer patients.
Liu W; Xu Y; Guan H; Meng H
Cancer Biomark; 2018; 22(3):487-493. PubMed ID: 29843213
[TBL] [Abstract][Full Text] [Related]
4. Lower expression of miR-218 in human breast cancer is associated with lymph node metastases, higher grades, and poorer prognosis.
Ahmadinejad F; Mowla SJ; Honardoost MA; Arjenaki MG; Moazeni-Bistgani M; Kheiri S; Teimori H
Tumour Biol; 2017 Aug; 39(8):1010428317698362. PubMed ID: 28857013
[TBL] [Abstract][Full Text] [Related]
5. MiR-34b is associated with clinical outcome in triple-negative breast cancer patients.
Svoboda M; Sana J; Redova M; Navratil J; Palacova M; Fabian P; Slaby O; Vyzula R
Diagn Pathol; 2012 Mar; 7():31. PubMed ID: 22439831
[TBL] [Abstract][Full Text] [Related]
6. Low expression of miR-597 is correlated with tumor stage and poor outcome in breast cancer.
Zhang XY; Liu DJ; Yuan RB; Zhang DH; Li SR; Zhang SH; Zhang LY
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):456-460. PubMed ID: 29424903
[TBL] [Abstract][Full Text] [Related]
7. Abnormal expression of miR-1 in breast carcinoma as a potent prognostic factor.
Minemura H; Takagi K; Miki Y; Shibahara Y; Nakagawa S; Ebata A; Watanabe M; Ishida T; Sasano H; Suzuki T
Cancer Sci; 2015 Nov; 106(11):1642-50. PubMed ID: 26331797
[TBL] [Abstract][Full Text] [Related]
8. Quantitative measurement of serum microRNA-21 expression in relation to breast cancer metastasis in Chinese females.
Wang G; Wang L; Sun S; Wu J; Wang Q
Ann Lab Med; 2015 Mar; 35(2):226-32. PubMed ID: 25729725
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of microRNA-7 and its Roles in the Regulation of Cisplatin Resistance in Lung Adenocarcinoma.
Cheng MW; Shen ZT; Hu GY; Luo LG
Cell Physiol Biochem; 2017; 42(2):660-672. PubMed ID: 28618418
[TBL] [Abstract][Full Text] [Related]
10. Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer.
Zhang Z; Zhang L; Yu G; Sun Z; Wang T; Tian X; Duan X; Zhang C
Cancer Chemother Pharmacol; 2020 Dec; 86(6):761-772. PubMed ID: 33068176
[TBL] [Abstract][Full Text] [Related]
11. Association of miR-1247-5p expression with clinicopathological parameters and prognosis in breast cancer.
Zhang P; Fan C; Du J; Mo X; Zhao Q
Int J Exp Pathol; 2018 Aug; 99(4):199-205. PubMed ID: 30175411
[TBL] [Abstract][Full Text] [Related]
12. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
[TBL] [Abstract][Full Text] [Related]
13. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.
Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y
Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377
[No Abstract] [Full Text] [Related]
14. Clinical Potential of miR-451 and miR-506 as a Prognostic Biomarker in Patients with Breast Cancer.
Du Y; Miao Z; Qiu L; Lv Y; Wang K; Guo L
J Healthc Eng; 2022; 2022():9578788. PubMed ID: 35070246
[TBL] [Abstract][Full Text] [Related]
15. Candidate circulating microRNAs as potential diagnostic and predictive biomarkers for the monitoring of locally advanced breast cancer patients.
Ibrahim AM; Said MM; Hilal AM; Medhat AM; Abd Elsalam IM
Tumour Biol; 2020 Oct; 42(10):1010428320963811. PubMed ID: 33028151
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of miR-330-3p: a novel independent indicator of poor prognosis in human breast cancer.
Wang H; Chen SH; Kong P; Zhang LY; Zhang LL; Zhang NQ; Gu H
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1726-1730. PubMed ID: 29630118
[TBL] [Abstract][Full Text] [Related]
17. Potential value of circulatory microRNA122 gene expression as a prognostic and metastatic prediction marker for breast cancer.
Saleh AA; Soliman SE; Habib MSE; Gohar SF; Abo-Zeid GS
Mol Biol Rep; 2019 Jun; 46(3):2809-2818. PubMed ID: 30835039
[TBL] [Abstract][Full Text] [Related]
18. MiR-27 as a prognostic marker for breast cancer progression and patient survival.
Tang W; Zhu J; Su S; Wu W; Liu Q; Su F; Yu F
PLoS One; 2012; 7(12):e51702. PubMed ID: 23240057
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of microRNA-155 expression in human breast cancer.
Chen J; Wang BC; Tang JH
J Surg Oncol; 2012 Sep; 106(3):260-6. PubMed ID: 22105810
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of miR-218 is associated with poor prognosis in patients with colorectal cancer.
Yu H; Gao G; Jiang L; Guo L; Lin M; Jiao X; Jia W; Huang J
Int J Clin Exp Pathol; 2013; 6(12):2904-11. PubMed ID: 24294377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]